Par Drugs and Chemicals Limited (PAR.NS)
INR 215.15
(5.23%)
INR 215.15
(5.23%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 956.4 Million | 950.95 Million | 742 Million | 598.8 Million | 550.96 Million | 455.97 Million |
| Cost of Revenue | 427.26 Million | 664.04 Million | 498.63 Million | 374.37 Million | 396.27 Million | 324.89 Million |
| Gross Profit | 529.13 Million | 286.9 Million | 243.36 Million | 224.42 Million | 154.69 Million | 131.08 Million |
| Operating Expenses | 58.28 Million | 141.37 Million | 116.81 Million | 92.8 Million | 90.17 Million | 79.38 Million |
| Selling, General and Administrative Expenses | 54.98 Million | 60.04 Million | 47.12 Million | 29.58 Million | 24.45 Million | 18 Million |
| Research and Development Expenses | 3.29 Million | 1 Million | 147.41 Thousand | 988 Thousand | 666.39 Thousand | 543.21 Thousand |
| Other Expenses | - | 2.38 Million | 1.83 Million | 508.02 Thousand | 66.85 Million | 63.3 Million |
| Cost and Expenses | 404.81 Million | 805.42 Million | 615.44 Million | 467.17 Million | 486.44 Million | 404.27 Million |
| Operating Income | 551.58 Million | 149.74 Million | 129.73 Million | 131.93 Million | 66.87 Million | 51.69 Million |
| Interest Expense | 1.07 Million | 24 Thousand | 3.76 Million | 6.02 Million | 7.54 Million | 18.11 Million |
| Income Tax Expense | 50.15 Million | 37.45 Million | 34.88 Million | 31.14 Million | 12.26 Million | 8.64 Million |
| Earnings before Tax | 195.16 Million | 150.79 Million | 127.03 Million | 147.26 Million | 59.91 Million | 32.83 Million |
| Net Income | 145.01 Million | 113.34 Million | 92.13 Million | 116.11 Million | 47.64 Million | 24.18 Million |
| Earnings Per Share Basic | 11.78 | 9.21 | 7.49 | 18.87 | 7.75 | 1.97 |
| Earnings Per Share Diluted | 11.78 | 9.21 | 7.49 | 18.87 | 7.75 | 1.97 |
| Weighted Average Shares Outstanding | 12.3 Million | 12.3 Million | 12.3 Million | 6.15 Million | 6.15 Million | 12.3 Million |
| Weighted Average Shares Outstanding (Diluted) | 12.3 Million | 12.3 Million | 12.3 Million | 6.15 Million | 6.15 Million | 12.3 Million |
| Gross Margin | 0.55 | 0.30 | 0.33 | 0.37 | 0.28 | 0.29 |
| EBIT Margin | 0.24 | 0.19 | 0.22 | 0.27 | 0.17 | 0.18 |
| Profit Margin | 0.15 | 0.12 | 0.12 | 0.19 | 0.09 | 0.05 |
| EBITDA | 228.17 Million | 182.07 Million | 162.54 Million | 181.87 Million | 94.48 Million | 82.14 Million |
| Earnings Before Tax Margin | 0.58 | 0.16 | 0.17 | 0.22 | 0.12 | 0.11 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 346.56 Million | 226.05 Million | 956.4 Million | 228.19 Million | 239.99 Million | 258.87 Million |
| Cost of Revenue | 143.26 Million | 74.86 Million | 427.26 Million | 99.26 Million | 101.51 Million | 110.23 Million |
| Gross Profit | 203.3 Million | 151.19 Million | 529.13 Million | 128.92 Million | 138.47 Million | 148.63 Million |
| Operating Expenses | 98.3 Million | 117.88 Million | 335.32 Million | 76.9 Million | 94.83 Million | 83.48 Million |
| Selling, General and Administrative Expenses | 98.3 Million | 12.61 Million | - | 76.9 Million | 94.83 Million | 83.48 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 117.88 Million | 2.42 Million | -480 Thousand | 2.29 Million | 491 Thousand |
| Cost and Expenses | 241.56 Million | 192.74 Million | 762.59 Million | 176.17 Million | 196.35 Million | 193.72 Million |
| Operating Income | 105 Million | 33.31 Million | 193.81 Million | 52.02 Million | 43.63 Million | 65.14 Million |
| Interest Expense | - | 199 Thousand | 1.07 Million | 452 Thousand | 196 Thousand | 267 Thousand |
| Income Tax Expense | 28.91 Million | 8.51 Million | 50.15 Million | 13.89 Million | 11.51 Million | 16.45 Million |
| Earnings before Tax | 114.86 Million | 33.85 Million | 195.16 Million | 51.08 Million | 45.73 Million | 65.37 Million |
| Net Income | 85.95 Million | 25.33 Million | 145.01 Million | 37.19 Million | 34.22 Million | 48.91 Million |
| Earnings Per Share Basic | 6.99 | 2.06 | - | 3.02 | 2.78 | 3.98 |
| Earnings Per Share Diluted | 6.99 | 2.06 | - | 3.02 | 2.78 | 3.98 |
| Weighted Average Shares Outstanding | 12.3 Million | 12.29 Million | 12.3 Million | 12.31 Million | 12.3 Million | 12.3 Million |
| Weighted Average Shares Outstanding (Diluted) | 12.3 Million | 12.29 Million | 12.3 Million | 12.31 Million | 12.3 Million | 12.3 Million |
| Gross Margin | 0.59 | 0.67 | 0.55 | 0.56 | 0.58 | 0.57 |
| EBIT Margin | 0.36 | 0.19 | - | 0.27 | 0.22 | 0.28 |
| Profit Margin | 0.25 | 0.11 | 0.15 | 0.16 | 0.14 | 0.19 |
| EBITDA | 123.94 Million | 43.08 Million | - | 60.93 Million | 52.29 Million | 73.62 Million |
| Earnings Before Tax Margin | 0.30 | 0.15 | 0.20 | 0.23 | 0.18 | 0.25 |
1522
REVB
KOCMT
6743
1950
CERGF